Pliant Therapeutics Inc
NASDAQ:PLRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pliant Therapeutics Inc
NASDAQ:PLRX
|
US |
|
Vince Holding Corp
NYSE:VNCE
|
US |
|
S
|
South32 Ltd
F:32Z
|
AU |
|
B
|
Becton Dickinson and Co
SWB:BOX
|
US |
|
Rexel SA
F:E7V
|
FR |
|
R
|
Rexel SA
XMUN:E7V
|
FR |
|
Tenax Therapeutics Inc
F:YBO
|
US |
|
B
|
BioCryst Pharmaceuticals Inc
XMUN:BO1
|
US |
|
South Plains Financial Inc
NASDAQ:SPFI
|
US |
Wall St Price Targets
PLRX Price Targets Summary
Pliant Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
PLRX is 2.72 USD with a low forecast of 2.02 USD and a high forecast of 3.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PLRX's stock price target?
Price Target
2.72
USD
According to Wall Street analysts, the average 1-year price target for
PLRX is 2.72 USD with a low forecast of 2.02 USD and a high forecast of 3.15 USD.